Leviticus Partners LP on HBIO, Sept 22, 2026

Leviticus Partners LP now owns 5.2%, as a passive investor.

Date
Sept 22, 2026
Who
Leviticus Partners LP
Fund
HBIO - Harvard Bioscience
Stake
5.2% (235,000 shares)
Type of notice
Updated notice
Document number
0001019432-26-000013

Open the original document at the SEC →

We read this document automatically. If something looks wrong, the original is the one that counts.

Back to HBIO